Re: Idir Ouzaid and Karim Bensalah. Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE. Eur Urol 2015;68:542-3

Matteo Santoni, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Alberto Briganti, Francesco Montorsi, Rodolfo Montironi, Daniele Santini

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalEuropean Urology
DOIs
StateAccepted/In press - 2015

ASJC Scopus subject areas

  • Urology

Cite this